摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-甲氧基-[1,1-联苯]-2-羧酸 | 92254-27-8

中文名称
4-甲氧基-[1,1-联苯]-2-羧酸
中文别名
——
英文名称
4-methoxy-[1,1'-biphenyl]-2-carboxylic acid
英文别名
4-methoxylbiphenyl-2-carboxylic acid;4-methoxy-2-biphenylcarboxylic acid;4-methoxybiphenyl-2-carboxylic acid;4-methoxy-biphenyl-2-carboxylic acid;4-Methoxy-biphenyl-2-carbonsaeure;4-Methoxy-2-biphenylcarbonsaeure;5-Methoxy-2-phenylbenzoic acid
4-甲氧基-[1,1-联苯]-2-羧酸化学式
CAS
92254-27-8
化学式
C14H12O3
mdl
MFCD06203600
分子量
228.247
InChiKey
FNXYJNSEVNHBFK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    135 °C
  • 沸点:
    379.3±30.0 °C(Predicted)
  • 密度:
    1.193±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.071
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2922299090

SDS

SDS:84b108ae396133d5b85b4ad1a533131c
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 5-Methoxy-2-phenylbenzoic acid
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 5-Methoxy-2-phenylbenzoic acid
CAS number: 92254-27-8

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C14H12O3
Molecular weight: 228.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-甲氧基-[1,1-联苯]-2-羧酸喹啉copper(I) oxide1,10-菲罗啉 作用下, 以 N-甲基吡咯烷酮 为溶剂, 反应 24.0h, 生成 4-甲氧基联苯
    参考文献:
    名称:
    通过钯催化的 C-H 官能化和苯甲酸的原脱羧合成对位取代芳烃的通用方法
    摘要:
    虽然已经开发了大量的邻位 C-H 官能化反应,并在间位 C-H 活化方面取得了一些突破,但对位 C-H 官能化仍处于起步阶段。在本文中,通过由钯催化的 C-H 官能化和随后的铜催化苯甲酸原脱羧组成的串联工艺开发了一种合成对位取代芳烃的通用策略。吸电子和给电子官能团都可以引入带有各种取代基的芳烃的对位。
    DOI:
    10.1055/s-0035-1560579
  • 作为产物:
    描述:
    参考文献:
    名称:
    Chronobiotic activity of N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]-propanamide. Synthesis and melatonergic pharmacology of fluoren-9-ylethyl amides
    摘要:
    A series of fluoren-9-yl ethyl amides (2) were synthesized and evaluated for human melatonin MT1 and MT2 receptor binding. N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]propanamide (2b) was selected and evaluated in functional assays measuring intrinsic activity at the human MT1 and MT2 receptors and demonstrated full agonism at both receptors. The chronobiotic properties of 2b were demonstrated in both acute and chronic rat models where 2b produced an acute phase advance of 32 min at 1 mg/kg and chronically entrained free-running rats with a mean effective dose of 0.23 mg/kg. Compound 2b is significantly less efficacious than melatonin in constricting human coronary artery. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2004.07.002
点击查看最新优质反应信息

文献信息

  • Intramolecular Aromatic C–H Acyloxylation Enabled by Iron Photocatalysis
    作者:Siqi Xia、Kunjun Hu、Chuanhu Lei、Jian Jin
    DOI:10.1021/acs.orglett.0c00002
    日期:2020.2.21
    protocol for the intramolecular aromatic C-H oxygenation of 2-biphenylcarboxylic acids has been achieved via iron photocatalysis. The 2-biphenylcarboxylic acids with a diverse array of substituents at both phenyl rings could furnish the oxygenation products in good to excellent yields. We speculate that the aryl carboxylate-iron(III) complexes should generate the aroyloxy radicals and iron(II) upon visible
    通过铁光催化已经实现了温和而有效的2-联苯基羧酸分子内芳族CH氧化的方案。在两个苯环上具有各种取代基的2-联苯羧酸可以很好的产率提供氧化产物。我们推测,在可见光照射下,芳基羧酸盐-铁(III)配合物应生成芳酰氧基和铁(II)。
  • Vitamin Catalysis: Direct, Photocatalytic Synthesis of Benzocoumarins via (−)-Riboflavin-Mediated Electron Transfer
    作者:Tobias Morack、Jan B. Metternich、Ryan Gilmour
    DOI:10.1021/acs.orglett.8b00052
    日期:2018.3.2
    photoactivated (−)-riboflavin (vitamin B2) to generate the heterocyclic core via photoinduced single electron transfer. Collectively, the inexpensive nature of the catalyst, ease of execution, and absence of external metal additives are a convincing endorsement for the incorporation of simple vitamins in contemporary catalysis.
    公开了一种操作简单的方案,以促进直接从联芳基羧酸进入苯并-3,4-香豆素,而无需底物预官能化。作为经典内酯化策略的补充,这种分离依赖于光活化的(-)-核黄素(维生素B 2)的氧化能力,可通过光诱导的单电子转移生成杂环核。总的来说,催化剂的廉价性质,易于实施以及不存在外部金属添加剂,都令人信服地赞同将简单的维生素掺入现代催化剂中。
  • Cerium Ammonium Nitrate-Mediated Access to Biaryl Lactones: Substrate Scopes and Mechanism Studies
    作者:Mianran Chao、Fang Wang、Linlin Xu、Yanping Ju、Zixuan Chen、Bin Wang、Peiwei Gong、Jinmao You、Ming Jin、Duyi Shen
    DOI:10.1021/acs.joc.1c01479
    日期:2021.10.1
    Herein we described an access to biaryl lactones from ortho-aryl benzoic acids via intramolecular O–H/C–H oxidative coupling with the commonly used cerium ammonium nitrate (CAN) as the one-electron oxidant under a thermal condition. The radical interrupting experiment suggested a radical process, while the kinetic isotope effect (KIE) showed that the C–H cleavage likely was not involved in the rate-determining
    在此,我们描述了从邻位获取联芳基内酯的方法-芳基苯甲酸通过分子内O-H / C-H氧化偶联与常用的硝酸铈铵(CAN)在热条件下作为单电子氧化剂。自由基中断实验表明了一个自由基过程,而动力学同位素效应 (KIE) 表明 C-H 裂解可能不参与速率决定步骤。竞争性反应,尤其是哈米特方程显着不同的 ρ 值,表明反应速率对芳基部分的电子性质比羧基部分的电子性质更敏感,这对应于第一个单电子转移 (SET) 步骤。此外,芳基部分的相当负的 ρ 值(-4.7)揭示了第二个分子内自由基加成过程的显着亲电性质,这也与产物产率和区域选择性一致。此外,对照实验揭示了第三步中的单电子也转移到了 CeIV代替分子氧。此外,还讨论了共溶剂三氟乙醇 (TFE) 的可能作用及其对 Ce IV物种的影响。这项工作通过提出对总反应速率和负责最后单电子转移的物种有更大影响的步骤来阐明可能的机制。
  • Palladium-Catalyzed Decarboxylative Annulation of 2-Arylbenzoic Acids with [60]Fullerene via C–H Bond Activation
    作者:Dian-Bing Zhou、Guan-Wu Wang
    DOI:10.1021/acs.orglett.5b00243
    日期:2015.3.6
    A convenient and highly efficient palladium-catalyzed decarboxylative annulation of 2-arylbenzoic acids with [60]fullerene has been exploited to synthesize the novel and scarce [60]fullerene-fused dihydrophenanthrenes. The use of Lewis acid ZnCl2 is crucial for the success of the present formal [4 + 2] annulation reaction. Plausible reaction pathways leading to the observed products have been proposed
    已经开发了一种方便高效的2-芳基苯甲酸与[60]富勒烯的钯催化脱羧环化反应,以合成新颖且稀少的[60]富勒烯稠合的二氢菲。路易斯酸ZnCl 2的使用对于当前正式的[4 + 2]环化反应的成功至关重要。已经提出了导致观察到的产物的合理的反应途径,并且还研究了富勒烯产物的电化学。
  • [EN] OREXIN RECEPTOR ANTAGONISTS WHICH ARE [ORTHO BI (HETERO )ARYL]-[2-(META BI (HETERO )ARYL)-PYRROLIDIN-1-YL]-METHANONE DERIVATIVES<br/>[FR] ANTAGONISTES DES RÉCEPTEURS DE L'OREXINE, QUI SONT DES DÉRIVÉS [ORTHO BI (HETERO )ARYL]-[2-(META BI (HETERO )ARYL)-PYRROLIDIN-1-YL]-METHANONE
    申请人:ACTELION PHARMACEUTICALS LTD
    公开号:WO2014057435A1
    公开(公告)日:2014-04-17
    The present invention relates to [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]- methanone derivatives of formula (I) wherein R, and the rings A1 A2 and A3 are as described in the description, to pharmaceutically acceptable salts thereof, to their preparation, to pharmaceutical compositions containing one or more compounds of formula (I), and to their use as pharmaceuticals, especially to their use as orexin receptor antagonists.
    本发明涉及公式(I)中的[ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-甲酮衍生物,其中R和环A1、A2和A3如描述中所述,以及其药用盐,其制备方法,含有一个或多个公式(I)化合物的药物组合物,以及它们作为药物的用途,特别是作为促进睡眠荷尔蒙受体拮抗剂的用途。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐